Skip to main content

Health condition

Pilocytic astrocytoma, a slow-growing childhood brain tumour with an excellent outlook.

A diagnosis like this is frightening for any family. The reassuring facts are that this is the lowest-grade brain tumour, it is often cured with surgery, and specialist teams have several gentle options when it is not.

Jump to treatment
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why trust this guide

  • 01

    Editorial team

    Written by our editorial team from the UK sources listed on each page.

  • 02

    Sourced from guidance

    Checked against the WHO classification, NICE, HeadSmart and specialist paediatric neuro-oncology sources listed at the end.

  • 03

    Current for 2026

    Reflects modern practice including molecular testing for BRAF changes and targeted MEK and BRAF inhibitor treatment.

Key facts

Pilocytic astrocytoma at a glance.

The essentials, in plain English - what it is, where it grows and how it is treated in the UK today.

  • What it is

    A slow-growing, WHO grade 1 tumour of astrocytes, the star-shaped support cells of the brain. It is well circumscribed and does not usually spread into surrounding brain.

  • Who gets it

    It is the commonest brain tumour in children, most often diagnosed between the ages of about 5 and 14. It can also occur in teenagers and, less often, adults.

  • Where it grows

    Most often in the cerebellum at the back of the brain. It can also arise in the optic pathway and hypothalamus, or the brainstem.

  • Cause

    Most cases carry a change in the BRAF gene, typically a KIAA1549-BRAF fusion. It is not caused by anything a parent did or did not do.

  • NF1 link

    Optic pathway tumours are strongly linked to neurofibromatosis type 1 (NF1). Children with NF1 are usually watched with vision checks and MRI.

  • Outlook

    Long-term survival is excellent. When a cerebellar tumour can be removed completely, surgery alone is often curative.

Why this guide matters

Grade 1 is the gentlest end of the scale.

The word tumour carries a great deal of fear. The three points below explain why this particular tumour is treated very differently from most others.

  • Slow growing and well defined

    Pilocytic astrocytomas are circumscribed. They tend to push against brain tissue rather than invade it, which is why complete removal is often possible.

  • Location shapes the plan

    A cerebellar tumour is usually removed. A tumour in the optic pathway, hypothalamus or brainstem is often treated more cautiously to protect sight and function.

  • The genetics now guide treatment

    Most tumours carry a BRAF change. Knowing this opens the door to targeted tablets that can control tumours surgery cannot safely reach.

How the diagnosis is made

From first symptoms to a clear plan.

The steps a paediatric neuro-oncology team will normally follow, in order - so you know what to expect and why.

  1. 01

    Assessing

    History and neurological exam

    A GP or paediatrician listens to the pattern of symptoms, checks balance, eye movements, vision and head size, and follows HeadSmart guidance.

  2. 02

    Assessing

    Prompt brain scan

    A suspected brain tumour in a child should be scanned within days. Where MRI is not immediately available, a CT scan may be used first.

  3. 03

    Assessing

    MRI of brain and spine

    MRI with contrast shows the classic cyst with an enhancing nodule. The whole spine is imaged to check for any spread.

  4. 04

    Confirming

    Specialist MDT review

    A paediatric neuro-oncology team, including neurosurgeon, oncologist, neuroradiologist and pathologist, agrees the safest plan together.

  5. 05

    Confirming

    Surgical planning

    Some children need urgent relief of hydrocephalus first. Surgery aims to remove as much tumour as can be done safely.

  6. 06

    Confirming

    Histology and molecular tests

    Tissue confirms a grade 1 pilocytic tumour. Testing for BRAF fusions or mutations guides any later targeted treatment.

  7. 07

    Planning

    Follow-up plan

    Scans are scheduled at agreed intervals, with support from rehabilitation, education and endocrine teams as needed.

Typical timeline: from first scan to a team-agreed plan within days to a couple of weeks. Tumours in the optic pathway are often diagnosed on MRI without a biopsy.

Symptoms

What families usually notice first.

Most symptoms come from pressure inside the skull or from the part of the brain the tumour sits in. Any of these can have many harmless causes, but a cluster or a persistent pattern deserves attention.

  • Morning headache

    Often worse on waking or when lying flat, and easing later in the day, as pressure inside the skull changes.

  • Vomiting

    Repeated vomiting, especially first thing in the morning and without a stomach bug, is a well-recognised early sign.

  • Unsteadiness and clumsiness

    A wide-based walk, frequent falls, or worsening handwriting may point to a cerebellar tumour.

  • Head tilt or neck stiffness

    A persistent tilt of the head, or a stiff neck without infection, can reflect pressure at the back of the brain.

  • Visual change

    Blurred or double vision, a squint, wobbling eye movements or reduced vision may occur, especially with optic pathway tumours.

  • Tiredness or change in behaviour

    Unusual drowsiness, irritability, or a fall-off in school performance can be a quiet sign of raised pressure.

  • Growth and puberty changes

    Hypothalamic tumours can affect appetite, weight, growth or the timing of puberty, sometimes years before diagnosis.

  • Red flag - symptoms persist

    Any child with symptoms lasting more than two weeks, or one severe symptom, deserves prompt medical assessment.

Treatment

How pilocytic astrocytoma is treated in the UK.

Surgery first where it is safe, careful watching where it is not needed, and gentler drug treatment before radiotherapy in children.

  • Maximal safe surgery

    Removal of as much tumour as can be done without harming function. For cerebellar tumours a complete resection is often curative.

  • Active monitoring

    A small stable remnant, or a tumour that is not causing problems, can be watched with regular MRI rather than treated straight away.

  • Hydrocephalus management

    Where fluid is blocked, a temporary drain, an endoscopic third ventriculostomy or a shunt relieves pressure quickly and safely.

  • Chemotherapy

    Carboplatin with vincristine is the standard first-line option for progressive tumours that cannot be fully removed, particularly in young children.

  • MEK inhibitors

    Oral targeted drugs such as selumetinib or trametinib act on the pathway driven by BRAF changes and may be used in specialist centres.

  • BRAF-targeted therapy

    Tumours with a BRAF V600E mutation may be treated with BRAF and MEK inhibitors, often within clinical trials or access programmes.

  • Radiotherapy, used sparingly

    Avoided in young children where possible because of late effects. Precise techniques, sometimes proton beam therapy, are considered later.

  • Neuro-rehabilitation and support

    Physiotherapy, occupational therapy, speech therapy, school liaison and psychological support help children recover and return to normal life.

What this guide is based on

The sources behind every claim on this page.

International classification, UK national guidance and specialist paediatric neuro-oncology standards, current at the time of last review.

Key references

Guidelines and standards we relied on.

A quiet reminder

This guide is for information, not medical advice.

Your child’s neurosurgeon and oncology team know their scans and history and can tell you which parts apply. If you are worried about symptoms, seek medical advice without delay.

  • WHO Classification of Tumours: Central Nervous System Tumours, 5th edition (2021).

  • NICE. Suspected cancer: recognition and referral (NG12), including brain and central nervous system cancers in children.

  • HeadSmart / Royal College of Paediatrics and Child Health. Guidance on early diagnosis of brain tumours in children and young people.

  • Children’s Cancer and Leukaemia Group (CCLG). Clinical guidance on paediatric low-grade glioma.

  • SIOP Europe low-grade glioma consensus guidance on surgery, chemotherapy and targeted therapy.

Red flags

When to seek help urgently.

Most headaches and bouts of sickness in children are harmless. These features are the ones that should prompt a same-day call to your GP, NHS 111, or 999 if severe.

  • Persistent morning vomiting

    Vomiting on waking without a clear stomach illness, especially with headache, needs same-day medical review.

  • Headache that wakes a child at night

    Headache that disturbs sleep, or is clearly worse lying down, suggests raised pressure and should not be put down to tiredness.

  • New unsteadiness or repeated falls

    A previously steady child who becomes clumsy or wide-based when walking should be seen promptly.

  • Sudden drowsiness or confusion

    Difficulty rousing, sudden confusion or a fast decline in alertness is an emergency - call 999 or go to A&E.

  • Visual loss or double vision

    Any new squint, double vision or loss of sight in a child needs urgent eye and neurological assessment.

  • Head tilt or neck stiffness

    A persistent head tilt with no injury or infection can signal pressure at the base of the brain.

  • Fits or seizures

    A first seizure, or a change in the pattern of known seizures, needs urgent medical assessment.

  • Rapid head enlargement in infants

    A bulging fontanelle, fast-growing head circumference or downward-looking eyes in an infant needs emergency care.

  • Symptoms lasting over two weeks

    HeadSmart advice is to seek a prompt scan when concerning symptoms persist or occur together.

Living with it

After treatment, life goes on.

Most children go on to school, friendships and adult life. Four things help most - steady follow-up, rehabilitation, an informed school and support for the whole family.

A quiet reminder

You do not have to work this out alone.

If you would like a second opinion or help understanding scans and treatment options, we can help you arrange a specialist consultation.

  1. 01 Follow-up

    Keep the scan schedule

    MRI surveillance is the safety net. It is usually more frequent at first, then spaced out over the years.

  2. 02 Recovery

    Rehabilitation is part of care

    Balance, coordination, speech or vision may need support after surgery. Progress is often steady over months.

  3. 03 Learning

    Tell school early

    Tiredness, slower processing or memory difficulties are common. An education plan helps a child feel understood.

  4. 04 Wellbeing

    Look after the whole family

    Anxiety and low mood are normal responses. Psychology, peer groups and charity support are there for children and parents alike.

Frequently asked

Everything we get asked about pilocytic astrocytoma.

Quick answers on grade, surgery, targeted treatment, radiotherapy and the long-term outlook.

  • What is a pilocytic astrocytoma?

    It is a slow-growing, WHO grade 1 brain tumour that arises from astrocytes, the support cells of the brain. It is well defined, often forms a fluid-filled cyst with a small solid nodule, and is the commonest brain tumour in children.

  • Is a pilocytic astrocytoma cancer?

    It is a tumour, and it is managed by cancer specialists, but it is the least aggressive grade. It rarely spreads and rarely turns into a higher-grade tumour. Many children are cured with surgery alone.

  • Can surgery cure it?

    Often, yes. When a cerebellar tumour can be removed completely, no further treatment is usually needed beyond follow-up scans. If a small piece is left behind because of location, it may stay stable for years and can simply be watched.

  • What if the tumour cannot be fully removed?

    Tumours in the optic pathway, hypothalamus or brainstem are harder to remove. Your team may watch a stable remnant, or use chemotherapy such as carboplatin and vincristine, or targeted MEK and BRAF inhibitors if the tumour is growing or causing symptoms.

  • Will my child need radiotherapy?

    Radiotherapy is avoided in young children wherever possible because of the risk of late effects on the developing brain. It is kept for selected cases after other options, and modern precise techniques help limit the dose to healthy tissue.

  • What is the long-term outlook?

    Overall survival is excellent, with the great majority of children alive and well ten years after diagnosis. Some live with late effects such as vision, hormone or learning difficulties, so ongoing follow-up and rehabilitation matter as much as the initial treatment.

Related content

Keep reading.